ALGEN.PAgenOway S.A.
Nov 12, 2026 — Dilution & Capital Restructuring Window
Chart by TradingViewThe schedule
- Thu12Nov
Critical window for a potential equity raise or debt restructuring to service the $13.7M debt load.
- Wed20Jan
Anticipated announcement regarding new pharmaceutical co-development or licensing deals utilizing genOway's model organism platforms.
- Sun31Jan
- Wed24Mar
Full-year 2026 results evaluating whether the company has successfully integrated its capacity expansions into recurring revenue streams.
- Sun2May
- Tue15Jun
Sector-wide multiple expansion as risk appetite for European micro-cap life science tools improves.
- Sun1Aug
- Sun31Oct
Past
- Thu24Sep
Release of semi-annual H1 2026 results, focusing heavily on operating cash burn versus the reported 5.96% YoY revenue growth.